| 51 |
22103869 | Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion. | 2011 Dec |
1 |
| 52 |
19796672 | Expression of aquaporins and vasopressin type 2 receptor in the stria vascularis of the cochlea. | 2010 Feb |
2 |
| 53 |
20205486 | Tolvaptan. | 2010 Mar 5 |
1 |
| 54 |
20606409 | Vasopressin and its immune effects in septic shock. | 2010 |
1 |
| 55 |
20653716 | Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism. | 2010 Jul |
1 |
| 56 |
20722976 | Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere's disease. | 2010 Nov |
1 |
| 57 |
19440390 | Involvement of the V2 vasopressin receptor in adaptation to limited water supply. | 2009 |
3 |
| 58 |
19554441 | Hyponatremia in heart failure: the role of arginine vasopressin and diuretics. | 2009 Aug |
1 |
| 59 |
19587238 | Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. | 2009 Jul 21 |
2 |
| 60 |
19895107 | Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. | 2009 Sep-Oct |
1 |
| 61 |
18519086 | Aquaporin 2 mutations in nephrogenic diabetes insipidus. | 2008 May |
3 |
| 62 |
18578504 | Phosphorylation analysis of G protein-coupled receptor by mass spectrometry: identification of a phosphorylation site in V2 vasopressin receptor. | 2008 Aug 1 |
1 |
| 63 |
20694082 | Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome. | 2008 Jun |
1 |
| 64 |
17287200 | Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R. | 2007 May |
2 |
| 65 |
17389737 | Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent. | 2007 May |
1 |
| 66 |
17516711 | Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application. | 2007 |
1 |
| 67 |
16825342 | Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. | 2006 Aug |
4 |
| 68 |
16843085 | Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. | 2006 Jul |
1 |
| 69 |
15650969 | [Advances in therapy for ascites and hepatorenal syndrome]. | 2005 Jan |
1 |
| 70 |
16093448 | Molecular biology of hereditary diabetes insipidus. | 2005 Oct |
1 |
| 71 |
16220067 | Comparison of two doses and dosing regimens of tolvaptan in congestive heart failure. | 2005 Nov |
1 |
| 72 |
15469988 | Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. | 2004 Dec |
1 |
| 73 |
11433224 | Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. | 2001 Jul |
1 |
| 74 |
11145096 | [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus]. | 2000 Dec 9 |
1 |
| 75 |
9756088 | Vasopressin receptor mutations causing nephrogenic diabetes insipidus. | 1998 Sep-Oct |
1 |
| 76 |
9831428 | Nephrogenic diabetes insipidus. | 1998 Nov |
1 |
| 77 |
9834976 | Pathogenesis of sodium and water retention in cardiac failure. | 1998 Nov |
3 |
| 78 |
7575330 | Diabetes insipidus. | 1995 Jul |
1 |
| 79 |
8808225 | Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. | 1995 Dec |
1 |
| 80 |
8140421 | Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. | 1994 Apr 1 |
1 |
| 81 |
1672792 | Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. | 1991 Jan |
1 |